Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Pharma News > 2024 > Preclinical studies cannot provide sufficient evidence that ivermectin helps treat cancer in people

Preclinical studies cannot provide sufficient evidence that ivermectin helps treat cancer in people

Preclinical studies cannot provide sufficient evidence that ivermectin helps treat cancer in people

Read also

Takeda

Takeda walks away from cell therapy in priority U-turn

Taysha Says

Taysha Says FDA Grants Breakthrough Therapy Designation To In Rett Syndrome

Intravitreal Injection of Retinal Progenitor

Intravitreal Injection of Retinal Progenitor

Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy

Mercury Bio

Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept